Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-07-02 @ 11:10 AM
Study NCT ID:
NCT05283057
Status:
COMPLETED
Last Update Posted:
2022-03-16
First Post:
2022-03-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Empagliflozin in Patients With Glomerulonephritis
Sponsor:
Kasr El Aini Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
KA-21-297
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None